BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 33751041)

  • 1. New biomarkers from multiomics approaches: improving risk prediction of atrial fibrillation.
    Kornej J; Hanger VA; Trinquart L; Ko D; Preis SR; Benjamin EJ; Lin H
    Cardiovasc Res; 2021 Jun; 117(7):1632-1644. PubMed ID: 33751041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Multiomics Approaches in Endometrial Cancer.
    Boroń D; Zmarzły N; Wierzbik-Strońska M; Rosińczuk J; Mieszczański P; Grabarek BO
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional genomics and epigenomics of atrial fibrillation.
    Victorino J; Alvarez-Franco A; Manzanares M
    J Mol Cell Cardiol; 2021 Aug; 157():45-55. PubMed ID: 33887329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of atrial fibrillation-practical applications for clinical management: if not now, when and how?
    Kany S; Reissmann B; Metzner A; Kirchhof P; Darbar D; Schnabel RB
    Cardiovasc Res; 2021 Jun; 117(7):1718-1731. PubMed ID: 33982075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting amino acids metabolic profile to identify novel metabolic characteristics in atrial fibrillation.
    She J; Guo M; Li H; Liu J; Liang X; Liu P; Zhou B; Liu S; Deng Y; Lou B; Sun C; Yuan Z; Wu Y
    Clin Sci (Lond); 2018 Oct; 132(19):2135-2146. PubMed ID: 30190284
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic Considerations in Atrial Fibrillation - Mechanistic Insights and Therapeutic Opportunities.
    Harada M; Melka J; Sobue Y; Nattel S
    Circ J; 2017 Nov; 81(12):1749-1757. PubMed ID: 29070758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PREventive left atrial appenDage resection for the predICtion of fuTure atrial fibrillation: design of the PREDICT AF study.
    van den Berg NWE; Neefs J; Berger WR; Boersma LVA; van Boven WJ; van Putte BP; Kaya A; Kawasaki M; Driessen AHG; de Groot JR;
    J Cardiovasc Med (Hagerstown); 2019 Nov; 20(11):752-761. PubMed ID: 31567634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases.
    Wang RS; Maron BA; Loscalzo J
    Arterioscler Thromb Vasc Biol; 2023 Apr; 43(4):493-503. PubMed ID: 36794589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging directions in the genetics of atrial fibrillation.
    Tucker NR; Ellinor PT
    Circ Res; 2014 Apr; 114(9):1469-82. PubMed ID: 24763465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNAs in Atrial Fibrillation: Current Status and Prospect.
    Zhou D; Yang K; Hu J; Shi J; Hu X
    J Cardiovasc Pharmacol; 2020 Jan; 75(1):10-17. PubMed ID: 31895877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinational Biomarkers for Atrial Fibrillation Derived from Atrial Appendage and Plasma Metabolomics Analysis.
    Lai S; Hua X; Gao R; Zeng L; Song J; Liu J; Zhang J
    Sci Rep; 2018 Nov; 8(1):16930. PubMed ID: 30446671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative Omics Approach to Identifying Genes Associated With Atrial Fibrillation.
    Wang B; Lunetta KL; Dupuis J; Lubitz SA; Trinquart L; Yao L; Ellinor PT; Benjamin EJ; Lin H
    Circ Res; 2020 Jan; 126(3):350-360. PubMed ID: 31801406
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomic basis of atrial fibrillation.
    Bapat A; Anderson CD; Ellinor PT; Lubitz SA
    Heart; 2018 Feb; 104(3):201-206. PubMed ID: 28893835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk.
    Nayor M; Brown KJ; Vasan RS
    Circ Res; 2021 Jan; 128(2):287-303. PubMed ID: 33476202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs and atrial fibrillation: mechanisms and translational potential.
    Luo X; Yang B; Nattel S
    Nat Rev Cardiol; 2015 Feb; 12(2):80-90. PubMed ID: 25421165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers and the prediction of atrial fibrillation: state of the art.
    O'Neal WT; Venkatesh S; Broughton ST; Griffin WF; Soliman EZ
    Vasc Health Risk Manag; 2016; 12():297-303. PubMed ID: 27486329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.
    Heijman J; Voigt N; Nattel S; Dobrev D
    Circ Res; 2014 Apr; 114(9):1483-99. PubMed ID: 24763466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiomics Analysis of Genetics and Epigenetics Reveals Pathogenesis and Therapeutic Targets for Atrial Fibrillation.
    Liu L; Huang J; Wei B; Mo J; Wei Q; Chen C; Yan W; Huang X; He F; Qin L; Huang H; Li X; Pan X
    Biomed Res Int; 2021; 2021():6644827. PubMed ID: 33834070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications.
    van den Berg NWE; Kawasaki M; Berger WR; Neefs J; Meulendijks E; Tijsen AJ; de Groot JR
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):345-365. PubMed ID: 28752208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of transcriptome-wide association study data and mRNA expression profiles identified candidate genes and pathways associated with atrial fibrillation.
    Zhang L; Liu L; Ma M; Cheng S; Cheng B; Li P; Wen Y; Du Y; Liang X; Zhao Y; Ding M; Xin Q; Liang C; Huang H; Zhang F
    Heart Vessels; 2019 Nov; 34(11):1882-1888. PubMed ID: 31065785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.